GCCAX
Price
$21.90
Change
+$0.69 (+3.25%)
Updated
Aug 15 closing price
Net Assets
453.79M
RSLCX
Price
$68.78
Change
-$0.17 (-0.25%)
Updated
Aug 15 closing price
Net Assets
80.31B
Interact to see
Advertisement

GCCAX vs RSLCX

Header iconGCCAX vs RSLCX Comparison
Open Charts GCCAX vs RSLCXBanner chart's image
GMO Climate Change R6
Price$21.90
Change+$0.69 (+3.25%)
VolumeN/A
Net Assets453.79M
American Funds SMALLCAP World R3
Price$68.78
Change-$0.17 (-0.25%)
VolumeN/A
Net Assets80.31B
GCCAX vs RSLCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCCAX vs. RSLCX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCCAX is a StrongBuy and RSLCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLCX has more cash in the bank: 80.3B vs. GCCAX (454M). GCCAX pays higher dividends than RSLCX: GCCAX (0.61) vs RSLCX (0.40). GCCAX was incepted earlier than RSLCX: GCCAX (6 years) vs RSLCX (23 years). RSLCX (1.30) is less costly to investors than GCCAX (0.83). GCCAX is a more actively managed with annual turnover of: 57.00 vs. RSLCX (32.00). GCCAX has a lower initial minimum investment than RSLCX: GCCAX (0) vs RSLCX (250). RSLCX annual gain was more profitable for investors over the last year : 9.95 vs. GCCAX (1.95). RSLCX return over 5 years is better than : 12.94 vs. GCCAX (-8.04).
GCCAXRSLCXGCCAX / RSLCX
Total Expense Ratio0.781.3060%
Annual Report Gross Expense Ratio0.831.3064%
Fund Existence6 years23 years-
Gain YTD19.9349.475210%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets454M80.3B1%
Annual Yield % from dividends0.610.40153%
Returns for 1 year1.959.9520%
Returns for 3 years-24.9520.72-120%
Returns for 5 years-8.0412.94-62%
Returns for 10 yearsN/A45.32-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRXP2.890.22
+8.24%
NRX Pharmaceuticals
VBNK10.780.24
+2.28%
VersaBank
LTC35.520.02
+0.06%
LTC Properties
EMCGU12.80N/A
N/A
Embrace Change Acquisition Corp
PRI261.67-1.17
-0.45%
PRIMERICA